Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology
暂无分享,去创建一个
[1] L. Bailey,et al. In situ pericardial extracardiac lateral tunnel Fontan operation: fifteen-year experience. , 2010, The Journal of thoracic and cardiovascular surgery.
[2] E. Neufeld,et al. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion. , 2009, Journal of Thoracic and Cardiovascular Surgery.
[3] F. Kirkham,et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.
[4] N. B. Lerner,et al. Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. , 2007, The Annals of thoracic surgery.
[5] E. Malec,et al. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] W. van Oeveren,et al. Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity , 2006, Critical care.
[7] D. Byrne,et al. Inhaled nitric oxide use in bidirectional Glenn anastomosis for elevated Glenn pressures. , 2006, The Annals of thoracic surgery.
[8] P. Monagle. Thrombosis in children with BT shunts, Glenns and Fontans , 2005 .
[9] Y. Cheung,et al. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure. , 2005, The American journal of cardiology.
[10] F. Pigula,et al. Interim mortality in infants with systemic-to-pulmonary artery shunts. , 2003, The Annals of thoracic surgery.
[11] P. D. del Nido,et al. Procoagulant and anticoagulant factor abnormalities following the Fontan procedure: increased factor VIII may predispose to thrombosis. , 2003, The Journal of thoracic and cardiovascular surgery.
[12] P. D. del Nido,et al. Coagulation factor abnormalities in patients with single-ventricle physiology immediately prior to the Fontan procedure. , 2002, The Annals of thoracic surgery.
[13] R. Junker,et al. Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study. , 2001, Thrombosis research.
[14] J. Rychik,et al. Thrombus formation after the Fontan operation. , 2001, The Annals of thoracic surgery.
[15] V. Hjortdal,et al. Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection , 2001, Heart.
[16] E. Bacha,et al. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation. , 2000, The Journal of thoracic and cardiovascular surgery.
[17] A. Ahlbom,et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[18] J. Tijssen,et al. Abnormalities in liver function and coagulation profile following the Fontan procedure , 1999, Heart.
[19] K. Huber,et al. Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[20] P. Monagle,et al. Coagulation abnormalities after Fontan procedures. , 1998, The Journal of thoracic and cardiovascular surgery.
[21] B. McCrindle,et al. Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. , 1998, The Journal of thoracic and cardiovascular surgery.
[22] W. Chandler,et al. Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels. , 1997, Circulation.
[23] E. Shinebourne,et al. Coagulation factor abnormalities after the Fontan procedure and its modifications. , 1997, The Journal of thoracic and cardiovascular surgery.
[24] J. Griffin,et al. Central venous thrombosis after cardiac operations in children. , 1996, The Journal of thoracic and cardiovascular surgery.
[25] D. Rosenthal,et al. Thromboembolic complications after Fontan operations. , 1995, Circulation.
[26] J. Morrow,et al. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry. , 1993, Journal of chromatography.
[27] H. Hillege,et al. Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations , 1990, The Lancet.